Arthur F. Ryan - May 1, 2023 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/**Arthur F. Ryan
Stock symbol
REGN
Transactions as of
May 1, 2023
Transactions value $
-$80,533
Form type
4
Date filed
5/3/2023, 04:01 PM
Previous filing
Apr 5, 2023
Next filing
Jun 2, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Sale -$12.8K -16 -0.08% $802.67 19K May 1, 2023 Direct F1, F2
transaction REGN Common Stock Sale -$24.1K -30 -0.16% $803.58 19K May 1, 2023 Direct F1, F3
transaction REGN Common Stock Sale -$1.61K -2 -0.01% $804.51 19K May 1, 2023 Direct F1, F4
transaction REGN Common Stock Sale -$4.03K -5 -0.03% $805.34 19K May 1, 2023 Direct F1, F5
transaction REGN Common Stock Sale -$12.1K -15 -0.08% $806.53 19K May 1, 2023 Direct F1, F6
transaction REGN Common Stock Sale -$13.7K -17 -0.09% $807.50 19K May 1, 2023 Direct F1, F7
transaction REGN Common Stock Sale -$12.1K -15 -0.08% $808.11 18.9K May 1, 2023 Direct F1, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on August 4, 2022.
F2 Represents volume-weighted average price of sales of 16 shares of Company stock on May 1, 2023 at prices ranging from $802.57 to $802.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2023 at each separate price.
F3 Represents volume-weighted average price of sales of 30 shares of Company stock on May 1, 2023 at prices ranging from $803.22 to $803.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2023 at each separate price.
F4 Represents volume-weighted average price of sales of 2 shares of Company stock on May 1, 2023 at prices ranging from $804.20 to $804.81. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2023 at each separate price.
F5 Represents volume-weighted average price of sales of 5 shares of Company stock on May 1, 2023 at prices ranging from $805.22 to $805.72. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2023 at each separate price.
F6 Represents volume-weighted average price of sales of 15 shares of Company stock on May 1, 2023 at prices ranging from $806.01 to $806.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2023 at each separate price.
F7 Represents volume-weighted average price of sales of 17 shares of Company stock on May 1, 2023 at prices ranging from $807.12 to $807.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2023 at each separate price.
F8 Represents volume-weighted average price of sales of 15 shares of Company stock on May 1, 2023 at prices ranging from $808.00 to $808.46. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2023 at each separate price.